Panel Discussion | Bringing Drugs Evaluated in Trial Cohorts Selected Based on Proteinuria Enrichment into Practical Application in Real-World Scenarios
Time: 11:00 am
day: Day 2 Track 3 AM
Details:
- Recognizing that the enrichment criteria employed in a trial do not necessarily limit a drug’s suitability exclusively to that specific population in real-world scenarios
- Translating the evidence generated in trials into suitable recommendations for treating patients with varying UACRs
- Discussing how clinical practice guidelines anticipate keeping pace with the rapidly evolving landscape of new CKD therapies
